April 26, 2018
EFPIA Japan Chairman Ole Moelskov Bech (left), PhRMA Japan-Chief Patrik Jonsson Japan’s revised price maintenance premium (PMP) scheme rolled out this April has failed to accurately define innovation, with the world’s best-selling drug and other important medicines inappropriately stripped of...read more